Incorporation of copper and strontium ions in TiO2 nanotubes via dopamine to enhance hemocompatibility and cytocompatibility

Abstract

Abstract Nanomaterials with unique nanotube arrays have attracted extensive attention in the field of blood-contacting biomaterials. In this study, the regular titanium dioxide nanotube arrays were first prepared on the pure titanium surface by anodic oxidation. Subsequently, copper ions (Cu2+) and strontium ions (Sr2+) were incorporated into the nanotubes by the chelation of dopamine to improve biocompatibility. The as-prepared TiO2 nanotubes had an inner diameter of about 60 nm and an outer diameter of 90–110 nm, as well as a tube length of 4–6 µm. The following annealing treatment and the incorporation of Cu2+ and Sr2+ had little effect on the morphology and dimensions of the nanotubes, but can significantly improve the hydrophilicity, and promote the adsorption of bovine serum albumin concurrently inhibit the adsorption of fibrinogen, showing the effect of selective protein adsorption. At the same time, loading Cu2+ and Sr2+ can also effectively inhibit platelet adhesion and activation, promote endothelial cell growth, and upregulate the expression of vascular endothelial growth factor and nitric oxide. Therefore, the results of this study showed that the incorporation of Cu2+ and Sr2+ into the TiO2 nanotubes can simultaneously improve the hemocompatibility and cytocompatibility of endothelial cells, which can enlarge the application of titanium-based biomaterials in cardiovascular devices such as a stent.